Rocío Montejano

9PUBLICATIONS
18CO-AUTHORS
NanomedicineMedical virologyGene and molecular therapyPredictive and prognostic markersBehavioural epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 18, 2026
Metformin and Weight Changes in Non-diabetic Older People With HIV (METFORAGING): A Double-Blind, Randomized, Placebo-Controlled, Pilot Trial.

|Feb 10, 2026
Impact of Proviral-DNA M184V/I on 96-Week Outcomes of DTG/3TC Maintenance Therapy: Results From the VOLVER Clinical Trial.

María De Lagarde, Rosa De Miguel, Mayra A Sigcha

|Mar 10, 2025
Three-Year Effectiveness of Bictegravir/Emtricitabine/Tenofovir Alafenamide as a Switch Strategy in the Real World.

Alejandro de Gea-Grela, Rafael Micán, Rosa de Miguel

|Oct 26, 2023
The Current Mismatch Between COVID-19 Clinical Trial Design and the Evolving Profile of Hospitalized Patients: A Retrospective Cohort Analysis.

Rocio Montejano, Alfredo Soler-Carracedo, Alberto M Borobia

|Jan 19, 2022
Effects of tenofovir on telomeres, telomerase and T cell maturational subset distribution in long-term aviraemic HIV-infected adults.

Javier Rodríguez-Centeno, Andrés Esteban-Cantos, Rocío Montejano

|Oct 15, 2021
Older HIV-infected adults: complex patients-comorbidity (I).

Rocío Montejano, Rosa de Miguel, José I Bernardino

Pageof 2

Frequent Collaborators

5 joint publications

José Ramón Arribas

3 joint publications

José Ignacio Bernardino

2 joint publications

Rafael Delgado

2 joint publications

Cristina Marcelo-Calvo